Advanced search
Start date
Betweenand


Study of the naturally acquired immune response against recombinant proteins corresponding to bloodless asexual stages of Plasmodium vivax

Full text
Author(s):
Tatiane Rodrigues de Oliveira
Total Authors: 1
Document type: Doctoral Thesis
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Conjunto das Químicas (IQ e FCF) (CQ/DBDCQ)
Defense date:
Examining board members:
Irene da Silva Soares; Fábio Trindade Maranhão Costa; Hernando Antonio Del Portillo Obando; Elaine Guadelupe Rodrigues; Nobuko Yoshida
Advisor: Irene da Silva Soares; Hernando Antonio Del Portillo Obando
Abstract

In the present study, we evaluated comparatively the acquired immune response to Plasmodium vivax in individuais from endemic areas of malaria using recombinant proteins based on three antigens from asexual blood stages of the parasite: Apical Membrane Antigen 1 (AMA-1), C-terminal region of the Merozoite Surface Protein1 (MSP1 19), and Variant Antigens of P. vivax (VIR). Seven recombinant proteins corresponding to the four VIR subfamilies (A, B, C and E) were included in this study. Initially, the different recombinant proteins were compared by ELISA with regard to the recognition by IgM, IgG, and IgG subclass of antibodies from 200 individuais with patent infection from the States of Pará and Rondônia. The frequencies of individuais that presented IgM ar IgG antibodies anti-VIR during the infection were 29.6% or 26.0%, respectively. We did not observe predominance of any IgG subclass during immune response anti-VIR, except in the case of the C subfamily which was predominantly recognized by IgG1 subclass. In contrast, the frequencies of the individuais that presented IgG antibodies to AMA-1 e MSP119 were significantly higher (57.0% and 90.5%, respectively). The cellular immune response to VIR antigens was evaluated by in vitro proliferative assays in mononuclear cells of the individuais recently exposed to P. vivax. We did not observe significantly proliferative responses to these antigens when we compared malaria exposed and non exposed individuais. Subsequently, we evaluated the pattern of cross recognition between antibodies and T cell against four VIR subfamilies after experimental immunization of BALB/c mice with each one of the proteins emulsified with Complete Freund\'s adjuvant. The IgG antibody titers of the mice immunized against each one of the recombinant proteins were detected by inhibition ELISA. High specific titers against VIR proteins were obtained after the second immunizing dose. Most importantly, we observed that the immunization schedule constituted by two sequential doses of each one of the VIR recombinant proteins were able to induce cross-reactive antibodies against the different VIR subfamilies. These studies were complemented by lymphocyte proliferative response analysis of the immunized mice after an in vitro stimulation with each one of the VIR proteins. Our results demonstrated that the VIR proteins presented specific and cross-reactive epitopes recognized by T cells. These data strongly suggested of the commons epitopes are present and showed that this schedule of immunization may be used as basis for future studies aimed at inducing protective immunity against vivax malaria in non human primates. (AU)